Diagnosing sepsis – The role of laboratory medicine

Clinica Chimica Acta

Volumn 460, Issue , 2016, Pages 203-210

  Fan, Shu Ling ^a   Miller, Nancy S ^a   Lee, John ^a   Remick, Daniel G ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Biomarkers; Bloodstream infections; Cytokines; D dimer; IL 6; Lactate; Procalcitonin; Rapid diagnostics; Sepsis

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYTOKINE; D DIMER; INTERLEUKIN 6; LACTIC ACID; MYOGLOBIN; NATRIURETIC FACTOR; PROADRENOMEDULLIN; PROCALCITONIN; TROPONIN; UROKINASE RECEPTOR;

ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; ANTIMICROBIAL THERAPY; BILIRUBIN BLOOD LEVEL; CLINICAL EVALUATION; CONSENSUS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; HUMAN; INFECTION; LABORATORY TEST; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MICROORGANISM DETECTION; MOLECULAR HYBRIDIZATION; MORTALITY; MULTICENTER STUDY (TOPIC); MYOCARDIAL DISEASE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; LABORATORY TECHNIQUE; PROCEDURES;

BIOMARKERS; CLINICAL LABORATORY TECHNIQUES; HUMANS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84978173106     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.07.002     Document Type: Review

References (85)

1. [1] Fleischmann, C., Scherag, A., Adhikari, N.K., Hartog, C.S., Tsaganos, T., Schlattmann, P., et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am. J. Respir. Crit. Care Med. 193 (2016), 259–272.
2. [2] Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The accp/sccm consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 101 (1992), 1644–1655.
3. [3] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315 (2016), 801–810.
4. [4] Vincent, J.L., Sakr, Y., Sprung, C.L., Ranieri, V.M., Reinhart, K., Gerlach, H., et al. Sepsis in european intensive care units: results of the soap study. Crit. Care Med. 34 (2006), 344–353.
5. [5] Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41 (2013), 580–637.
6. [6] Levy, M.M., Rhodes, A., Phillips, G.S., Townsend, S.R., Schorr, C.A., Beale, R., et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit. Care Med. 43 (2015), 3–12.
7. [7] Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34 (2006), 1589–1596.
8. [8] Wenzel, R.P., Edmond, M.B., Managing antibiotic resistance. N. Engl. J. Med. 343 (2000), 1961–1963.
9. [9] USA B, Press Release fda Approved pct for Sepsis. http://www.marketwired.com/press-release/brahms-receives-fda-clearance-to-market-automated-procalcitonin-pct-test-841588.htm (Accessed May 26, 2015 2015).
10. [10] Wacker, C., Prkno, A., Brunkhorst, F.M., Schlattmann, P., Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect. Dis. 13 (2013), 426–435.
11. [11] Anand, D., Das, S., Bhargava, S., Srivastava, L.M., Garg, A., Tyagi, N., et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. J. Crit. Care, 30, 2015 (218 e7-12).
12. [12] Schuetz, P., Chiappa, V., Briel, M., Greenwald, J.L., Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch. Intern. Med. 171 (2011), 1322–1331.
13. [13] Sridharan, P., Chamberlain, R.S., The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?. Surg. Infect. 14 (2013), 489–511.
14. [14] Faix, J.D., Biomarkers of sepsis. Crit. Rev. Clin. Lab. Sci. 50 (2013), 23–36.
15. [15] Andersen, L.W., Mackenhauer, J., Roberts, J.C., Berg, K.M., Cocchi, M.N., Donnino, M.W., Etiology and therapeutic approach to elevated lactate levels. Mayo Clin. Proc. 88 (2013), 1127–1140.
16. [16] Shapiro, N.I., Howell, M.D., Talmor, D., Nathanson, L.A., Lisbon, A., Wolfe, R.E., Weiss, J.W., Serum lactate as a predictor of mortality in emergency department patients with infection. Ann. Emerg. Med. 45 (2005), 524–528.
17. [17] Howell, M.D., Donnino, M., Clardy, P., Talmor, D., Shapiro, N.I., Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 33 (2007), 1892–1899.
18. [18] Mikkelsen, M.E., Miltiades, A.N., Gaieski, D.F., Goyal, M., Fuchs, B.D., Shah, C.V., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit. Care Med. 37 (2009), 1670–1677.
19. [19] Junhasavasdikul, D., Theerawit, P., Ingsathit, A., Kiatboonsri, S., Lactate and combined parameters for triaging sepsis patients into intensive care facilities. J. Crit. Care 33 (2016), 71–77.
20. [20] Shin, T.G., Jo, I.J., Hwang, S.Y., Jeon, K., Suh, G.Y., Choe, E., et al. Comprehensive interpretation of central venous oxygen saturation and blood lactate levels during resuscitation of patients with severe sepsis and septic shock in the emergency department. Shock 45 (2016), 4–9.
21. [21] Dugas, A.F., Mackenhauer, J., Salciccioli, J.D., Cocchi, M.N., Gautam, S., Donnino, M.W., Prevalence and characteristics of nonlactate and lactate expressors in septic shock. J. Crit. Care 27 (2012), 344–350.
22. [22] Ugarte, H., Silva, E., Mercan, D., De Mendonca, A., Vincent, J.L., Procalcitonin used as a marker of infection in the intensive care unit. Crit. Care Med. 27 (1999), 498–504.
23. [23] Reny, J.L., Vuagnat, A., Ract, C., Benoit, M.O., Safar, M., Fagon, J.Y., Diagnosis and follow-up of infections in intensive care patients: value of c-reactive protein compared with other clinical and biological variables. Crit. Care Med. 30 (2002), 529–535.
24. [24] Povoa, P., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P., Sabino, H., C-reactive protein as a marker of infection in critically ill patients. Clin. Microbiol. Infect. 11 (2005), 101–108.
25. [25] Povoa, P., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P., Sabino, H., Early identification of intensive care unit-acquired infections with daily monitoring of c-reactive protein: a prospective observational study. Crit. Care, 10, 2006, R63.
26. [26] Lobo, S.M., Lobo, F.R., Bota, D.P., Lopes-Ferreira, F., Soliman, H.M., Melot, C., Vincent, J.L., C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123 (2003), 2043–2049.
27. [27] Castelli, G.P., Pognani, C., Cita, M., Stuani, A., Sgarbi, L., Paladini, R., Procalcitonin, c-reactive protein, white blood cells and sofa score in icu: diagnosis and monitoring of sepsis. Minerva Anestesiol. 72 (2006), 69–80.
28. [28] Schmit, X., Vincent, J.L., The time course of blood c-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 36 (2008), 213–219.
29. [29] Zhang, Z., Ni, H., C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review. Anaesth. Intensive Care 39 (2011), 854–861.
30. [30] Du, B., Pan, J., Chen, D., Li, Y., Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin. Med. J. 116 (2003), 538–542.
31. [31] Kellum, J.A., Kong, L., Fink, M.P., Weissfeld, L.A., Yealy, D.M., Pinsky, M.R., et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (genims) study. Arch. Intern. Med. 167 (2007), 1655–1663.
32. [32] Wong, H.R., Cvijanovich, N., Wheeler, D.S., Bigham, M.T., Monaco, M., Odoms, K., et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am. J. Respir. Crit. Care Med. 178 (2008), 276–282.
33. [33] Calfee, C.S., Thompson, B.T., Parsons, P.E., Ware, L.B., Matthay, M.A., Wong, H.R., Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit. Care Med. 38 (2010), 1436–1441.
34. [34] Carrigan, S.D., Scott, G., Tabrizian, M., Toward resolving the challenges of sepsis diagnosis. Clin. Chem. 50 (2004), 1301–1314.
35. [35] Prucha, M., Bellingan, G., Zazula, R., Sepsis biomarkers. Clin. Chim. Acta 440C (2014), 97–103.
36. [36] Kinasewitz, G.T., Yan, S.B., Basson, B., Comp, P., Russell, J.A., Cariou, A., et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [isrctn74215569]. Crit. Care 8 (2004), R82–R90.
37. [37] Schuetz, P., Marlowe, R.J., Mueller, B., The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (copd): a qualitative clinical review. Clin. Chem. Lab. Med. 53 (2015), 521–539.
38. [38] Grolimund, E., Kutz, A., Marlowe, R.J., Vogeli, A., Alan, M., Christ-Crain, M., et al. Long-term prognosis in copd exacerbation: role of biomarkers, clinical variables and exacerbation type. COPD, 2014.
39. [39] Schuetz, P., Aujesky, D., Muller, C., Muller, B., Biomarker-guided personalised emergency medicine for all - hope for another hype?. Swiss Med. Wkly., 145, 2015, w14079.
40. [40] Debiane, L., Hachem, R.Y., Al Wohoush, I., Shomali, W., Bahu, R.R., Jiang, Y., et al. The utility of proadrenomedullin and procalcitonin in comparison to c-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit. Care Med. 42 (2014), 2500–2507.
41. [41] Masson, S., Caironi, P., Fanizza, C., Carrer, S., Caricato, A., Fassini, P., et al. Sequential n-terminal pro-b-type natriuretic peptide and high-sensitivity cardiac troponin measurements during albumin replacement in patients with severe sepsis or septic shock. Crit. Care Med. 44 (2016), 707–716.
42. [42] Caironi, P., Tognoni, G., Masson, S., Fumagalli, R., Pesenti, A., Romero, M., et al. Albumin replacement in patients with severe sepsis or septic shock. N. Engl. J. Med. 370 (2014), 1412–1421.
43. [43] Tettamanti, C., Hervet, T., Grabherr, S., Palmiere, C., Elevation of nt-probnp and cardiac troponins in sepsis-related deaths: a forensic perspective. Int. J. Legal Med., 2016.
44. [44] Cheng, H., Fan, W.Z., Wang, S.C., Liu, Z.H., Zang, H.L., Wang, L.Z., et al. N-terminal pro-brain natriuretic peptide and cardiac troponin i for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: a retrospective study. J. Crit. Care, 30, 2015 (654 e9–14).
45. [45] Yao, L., Liu, Z., Zhu, J., Li, B., Chai, C., Tian, Y., Higher serum level of myoglobin could predict more severity and poor outcome for patients with sepsis. Am. J. Emerg. Med., 2016.
46. [46] Jensen, J.U., Hein, L., Lundgren, B., Bestle, M.H., Mohr, T.T., Andersen, M.H., et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit. Care Med. 39 (2011), 2048–2058.
47. [47] Kelly, B.J., Lautenbach, E., Nachamkin, I., Coffin, S.E., Gerber, J.S., Fuchs, B.D., et al. Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis. Diagn. Microbiol. Infect. Dis. 85 (2016), 109–115.
48. [48] Shapiro, N.I., Trzeciak, S., Hollander, J.E., Birkhahn, R., Otero, R., Osborn, T.M., et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit. Care Med. 37 (2009), 96–104.
49. [49] Andaluz-Ojeda, D., Bobillo, F., Iglesias, V., Almansa, R., Rico, L., Gandia, F., et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 57 (2012), 332–336.
50. [50] Weber, G.F., Chousterman, B.G., He, S., Fenn, A.M., Nairz, M., Anzai, A., et al. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 347 (2015), 1260–1265.
51. [51] O'Callaghan, D.J., O'Dea, K.P., Scott, A.J., Takata, M., Gordon, A.C., Monocyte tumor necrosis factor-alpha-converting enzyme catalytic activity and substrate shedding in sepsis and noninfectious systemic inflammation. Crit. Care Med. 43 (2015), 1375–1385.
52. [52] Read, C.B., Kuijper, J.L., Hjorth, S.A., Heipel, M.D., Tang, X., Fleetwood, A.J., et al. Cutting edge: identification of neutrophil pglyrp1 as a ligand for trem-1. J. Immunol. 194 (2015), 1417–1421.
53. [53] Motal, M.C., Klaus, D.A., Lebherz-Eichinger, D., Tudor, B., Hamp, T., Wiegele, M., et al. Increased plasma vaspin concentration in patients with sepsis: an exploratory examination. Biochem. Med. 25 (2015), 90–96.
54. [54] Benz, F., Roy, S., Trautwein, C., Roderburg, C., Luedde, T., Circulating micrornas as biomarkers for sepsis. Int. J. Mol. Sci., 17, 2016.
55. [55] Dumache, R., Rogobete, A.F., Bedreag, O.H., Sarandan, M., Cradigati, A.C., Papurica, M., et al. Use of mirnas as biomarkers in sepsis. Anal. Cell. Pathol. (Amst.), 2015, 2015, 186716.
56. [56] Bar-Or, D., Carrick, M.M., Mains, C.W., Rael, L.T., Slone, D., Brody, E.N., Sepsis, oxidative stress, and hypoxia: are there clues to better treatment?. Redox Rep. 20 (2015), 193–197.
57. [57] Masson, S., Caironi, P., Fanizza, C., Thomae, R., Bernasconi, R., Noto, A., et al. Circulating presepsin (soluble cd14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized albios trial. Intensive Care Med. 41 (2015), 12–20.
58. [58] Petroni, K.C., Shen, L., Guyre, P.M., Modulation of human polymorphonuclear leukocyte igg fc receptors and fc receptor-mediated functions by ifn-gamma and glucocorticoids. J. Immunol. 140 (1988), 3467–3472.
59. [59] Muller Kobold, A.C., Zijlstra, J.G., Koene, H.R., de Haas, M., Kallenberg, C.G., Tervaert, J.W., Levels of soluble fc gammariii correlate with disease severity in sepsis. Clin. Exp. Immunol. 114 (1998), 220–227.
60. [60] Groselj-Grenc, M., Ihan, A., Derganc, M., Neutrophil and monocyte cd64 and cd163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediat. Inflamm., 2008, 2008, 202646.
61. [61] Leino, L., Sorvajarvi, K., Katajisto, J., Laine, M., Lilius, E.M., Pelliniemi, T.T., et al. Febrile infection changes the expression of igg fc receptors and complement receptors in human neutrophils in vivo. Clin. Exp. Immunol. 107 (1997), 37–43.
62. [62] Fadlon, E., Vordermeier, S., Pearson, T.C., Mire-Sluis, A.R., Dumonde, D.C., Phillips, J., et al. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of cd64. Blood 91 (1998), 266–274.
63. [63] Quayle, J.A., Watson, F., Bucknall, R.C., Edwards, S.W., Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin g receptor, fc gamma ri (cd64): role of immune complexes and cytokines in induction of receptor expression. Immunology 91 (1997), 266–273.
64. [64] Qureshi, S.S., Lewis, S.M., Gant, V.A., Treacher, D., Davis, B.H., Brown, K.A., Increased distribution and expression of cd64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (sirs). Clin. Exp. Immunol. 125 (2001), 258–265.
65. [65] Davis, B.H., Bigelow, N.C., Comparison of neutrophil cd64 expression, manual myeloid immaturity counts, and automated hematology analyzer flags as indicators of infection or sepsis. Lab. Hematol. 11 (2005), 137–147.
66. [66] Ng, P.C., Li, K., Wong, R.P., Chui, K.M., Wong, E., Fok, T.F., Neutrophil cd64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr. Res. 51 (2002), 296–303.
67. [67] Bloos, F., Reinhart, K., Rapid diagnosis of sepsis. Virulence 5 (2014), 154–160.
68. [68] Schorr, C.A., Zanotti, S., Dellinger, R.P., Severe sepsis and septic shock: management and performance improvement. Virulence 5 (2014), 190–199.
69. [69] Mancini, N., Carletti, S., Ghidoli, N., Cichero, P., Burioni, R., Clementi, M., The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin. Microbiol. Rev. 23 (2010), 235–251.
70. [70] Bacconi, A., Richmond, G.S., Baroldi, M.A., Laffler, T.G., Blyn, L.B., Carolan, H.E., et al. Improved sensitivity for molecular detection of bacterial and candida infections in blood. J. Clin. Microbiol. 52 (2014), 3164–3174.
71. [71] Holtzman, C., Whitney, D., Barlam, T., Miller, N.S., Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J. Clin. Microbiol. 49 (2011), 1581–1582.
72. [72] Hemmert, A., Garrone, N., Rapid methods for pathogen detection in blood stream infections. MLO Med. Lab. Obs. 45 (2013), 38–39.
73. [73] Zheng, X., Polanco, W., Carter, D., Shulman, S., Rapid identification of pathogens from pediatric blood cultures by use of the filmarray blood culture identification panel. J. Clin. Microbiol. 52 (2014), 4368–4371.
74. [74] Wenzler, E., Wong, J.R., Goff, D.A., Jankowski, C.A., Bauer, K.A., Controversies in antimicrobial stewardship: focus on new rapid diagnostic technologies and antimicrobials. Antibiotics, 5, 2016.
75. [75] Wojewoda, C., Education Committee of the Academy of Clinical Laboratory P, Scientists, Pathology consultation on matrix-assisted laser desorption ionization-time of flight mass spectrometry for microbiology. Am. J. Clin. Pathol. 140 (2013), 143–148.
76. [76] Clark, A.E., Kaleta, E.J., Arora, A., Wolk, D.M., Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin. Microbiol. Rev. 26 (2013), 547–603.
77. [77] Perez, K.K., Olsen, R.J., Musick, W.L., Cernoch, P.L., Davis, J.R., Land, G.A., et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch. Pathol. Lab. Med. 137 (2013), 1247–1254.
78. [78] Barghouthi, S.A., A universal method for the identification of bacteria based on general pcr primers. Indian J. Microbiol. 51 (2011), 430–444.
79. [79] Liesenfeld, O., Lehman, L., Hunfeld, K.P., Kost, G., Molecular diagnosis of sepsis: new aspects and recent developments. Eur. J. Microbiol. Immunol. 4 (2014), 1–25.
80. [80] Beyda, N.D., Alam, M.J., Garey, K.W., Comparison of the t2dx instrument with t2candida assay and automated blood culture in the detection of candida species using seeded blood samples. Diagn. Microbiol. Infect. Dis. 77 (2013), 324–326.
81. [81] Abou Tayoun, A.N., Burchard, P.R., Malik, I., Scherer, A., Tsongalis, G.J., Democratizing molecular diagnostics for the developing world. Am. J. Clin. Pathol. 141 (2014), 17–24.
82. [82] Mezger, A., Gullberg, E., Goransson, J., Zorzet, A., Herthnek, D., Tano, E., et al. A general method for rapid determination of antibiotic susceptibility and species in bacterial infections. J. Clin. Microbiol. 53 (2015), 425–432.
83. [83] Boldrick, J.C., Alizadeh, A.A., Diehn, M., Dudoit, S., Liu, C.L., Belcher, C.E., et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 972–977.
84. [84] Sweeney, T.E., Shidham, A., Wong, H.R., Khatri, P., A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci. Transl. Med., 7, 2015, 287ra71.
85. [85] Henriquez-Camacho, C., Losa, J., Biomarkers for sepsis. BioMed Res. Int., 2014, 2014, 547818.